Search Results - "Karikó, Katalin"

Refine Results
  1. 1

    Developing mRNA for Therapy by Karikó, Katalin

    Published in Keio journal of medicine (2022)
    “…Messenger RNA was discovered in 1961 and it took 60 years until the first mRNA became FDA-approved product in the form of COVID-19 mRNA vaccine. During those…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Inhibition of Toll-like Receptor and Cytokine Signaling-A Unifying Theme in Ischemic Tolerance by Karikó, Katalin, Weissman, Drew, Welsh, Frank A.

    “…Cerebral ischemia triggers acute inflammation, which exacerbates primary brain damage. Activation of the innate immune system is an important component of this…”
    Get full text
    Journal Article Book Review
  6. 6

    In vitro-Transcribed mRNA Therapeutics: Out of the Shadows and Into the Spotlight by Karikó, Katalin

    Published in Molecular therapy (10-04-2019)
    “…Warren and Lin2 review this field and give an exquisite account of the development of IVT mRNA encoding key transcription factors for production of human stem…”
    Get full text
    Journal Article
  7. 7
  8. 8

    mRNA-based therapeutics — developing a new class of drugs by Sahin, Ugur, Karikó, Katalin, Türeci, Özlem

    Published in Nature reviews. Drug discovery (01-10-2014)
    “…Key Points Messenger RNA (mRNA) is a pivotal molecule of life, involved in almost all aspects of cell biology. As the subject of basic and applied research for…”
    Get full text
    Journal Article
  9. 9

    Modified uridines are the key to a successful message by Karikó, Katalin

    Published in Nature reviews. Immunology (01-10-2021)
    “…Katalin Karikó describes the discovery that replacing uridine with pseudouridine renders RNA non-immunogenic. This paved the way for developing mRNA for…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA by Karikó, Katalin, Muramatsu, Hiromi, Ludwig, János, Weissman, Drew

    Published in Nucleic acids research (01-11-2011)
    “…In vitro-transcribed mRNA has great therapeutic potential to transiently express the encoded protein without the adverse effects of viral and DNA-based…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine by Muramatsu, Hiromi, Lam, Kieu, Bajusz, Csaba, Laczkó, Dorottya, Karikó, Katalin, Schreiner, Petra, Martin, Alan, Lutwyche, Peter, Heyes, James, Pardi, Norbert

    Published in Molecular therapy (04-05-2022)
    “…Lipid nanoparticle (LNP)-formulated nucleoside-modified mRNA vaccines have proven to be very successful in the fight against the coronavirus disease 2019…”
    Get full text
    Journal Article
  15. 15

    A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA by Baiersdörfer, Markus, Boros, Gábor, Muramatsu, Hiromi, Mahiny, Azita, Vlatkovic, Irena, Sahin, Ugur, Karikó, Katalin

    Published in Molecular therapy. Nucleic acids (15-04-2019)
    “…The increasing importance of in vitro-transcribed (IVT) mRNA for synthesizing the encoded therapeutic protein in vivo demands the manufacturing of pure mRNA…”
    Get full text
    Journal Article
  16. 16

    The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy by Foster, Jessica B., Barrett, David M., Karikó, Katalin

    Published in Molecular therapy (10-04-2019)
    “…Adoptive T cell therapy is a form of cellular therapy that utilizes human immune cells, often empowered by the expression of recombinant proteins, to attack…”
    Get full text
    Journal Article
  17. 17

    Elimination of large tumors in mice by mRNA-encoded bispecific antibodies by Stadler, Christiane R, Bähr-Mahmud, Hayat, Celik, Leyla, Hebich, Bernhard, Roth, Alexandra S, Roth, René P, Karikó, Katalin, Türeci, Özlem, Sahin, Ugur

    Published in Nature medicine (01-07-2017)
    “…Bispecific antibodies that connect T cells with tumor cells can be delivered in the form of in vitro –transcribed pharmacologically optimized mRNA; when…”
    Get full text
    Journal Article
  18. 18

    Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies by Pardi, Norbert, Parkhouse, Kaela, Kirkpatrick, Ericka, McMahon, Meagan, Zost, Seth J., Mui, Barbara L., Tam, Ying K., Karikó, Katalin, Barbosa, Christopher J., Madden, Thomas D., Hope, Michael J., Krammer, Florian, Hensley, Scott E., Weissman, Drew

    Published in Nature communications (22-08-2018)
    “…Currently available influenza virus vaccines have inadequate effectiveness and are reformulated annually due to viral antigenic drift. Thus, development of a…”
    Get full text
    Journal Article
  19. 19

    Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin by Karikó, Katalin, Muramatsu, Hiromi, Keller, Jason M, Weissman, Drew

    Published in Molecular therapy (01-05-2012)
    “…Advances in the optimization of in vitro-transcribed mRNA are bringing mRNA-mediated therapy closer to reality. In cultured cells, we recently achieved high…”
    Get full text
    Journal Article
  20. 20